|
|
To view our documents, you must use software that is capable of opening PDF (portable document format) files. Our
documents are compatible with Adobe® v6.0 and higher. |
 |
|
DECEMBER 21, 2009
CPEX PHARMACEUTICALS ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2A CLINICAL TRIAL OF NASULIN™
NOVEMBER 05, 2009
CPEX’S NASULIN INSULIN THERAPY FEATURED IN AN ORAL PRESENTATION AND FOUR ABSTRACTS AT THE
NINTH ANNUAL DIABETES TECHNOLOGY MEETING
NOVEMBER 04, 2009
CPEX PHARMACEUTICALS REPORTS THIRD-QUARTER 2009 FINANCIAL RESULTS
SEPTEMBER 15, 2009
CPEX PHARMACEUTICALS TO PRESENT AT NINTH ANNUAL DIABETES TECHNOLOGY MEETING
AUGUST 05, 2009
CPEX PHARMACEUTICALS REPORTS SECOND-QUARTER 2009 FINANCIAL RESULTS
MAY 06, 2009
CPEX PHARMACEUTICALS REPORTS FIRST-QUARTER 2009 FINANCIAL RESULTS
MARCH 05, 2009
CPEX PHARMACEUTICALS REPORTS 2008 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS
FEBRUARY 26, 2009
CPEX PHARMACEUTICALS ANNOUNCES COMPLETION OF PHASE 2 TRIAL FOR UROLOGY DRUG BY SERENITY PHARMACEUTICALS
FEBRUARY 24, 2009
CPEX PHARMACEUTICALS INITIATES PHASE II CLINICAL TRIAL OF NASULIN®
FEBRUARY 03, 2009
CPEX PHARMACEUTICALS TO PRESENT AT THE 11TH ANNUAL BIO CEO & INVESTOR CONFERENCE
FEBRUARY 02, 2009
CPEX PHARMACEUTICALS ANNOUNCES APPOINTMENT OF NEW CHIEF MEDICAL OFFICER
If you are interested in receiving an investor packet, please call us at 603.658.6100.
|
